Table 1 Relationship between miR-5000-3p expression and tumor characteristics in patients with colorectal cancer.

From: miR-5000-3p confers oxaliplatin resistance by targeting ubiquitin-specific peptidase 49 in colorectal cancer

Features

No. of patients

miR-5000-3p expression

p value

Low

High

All patients

403

201

202

 

Age (years)

   

0.008**

<69

199

88

111

 

≥69

204

117

87

 

Gender

   

0.496

Male

215

113

102

 

Female

188

92

96

 

T Infiltrate

   

0.023*

T1

10

8

2

 

T2

72

39

33

 

T3

270

140

130

 

T4

50

18

32

 

Lymphatic metastasis (N)

   

0.400

0

253

133

120

 

1

86

41

45

 

2

64

31

33

 

Metastasis (M)

   

0.666

0

292

150

142

 

1

56

27

29

 

Stage

   

0.290

1

72

41

31

 

2

167

84

83

 

3

97

47

50

 

4

56

27

29

 
  1. *p < 0.05 and **p < 0.01.